• English
  • 简体中文
Login Register
Current Location: Home > Feedback Help Print

【结 构 式】

【药物名称】ICI-200880

【化学名称】1(RS)-N-[4-[N-(4-Chlorophenylsulfonyl)carbamoyl]benzoyl]-L-valyl-N-[2-methyl-1-(trifluoroacetyl)propyl]-L-prolinamide

【CA登记号】105080-50-0, 105120-02-3 ((R)-isomer), 105120-70-5 ((S)-isomer)

【 分 子 式 】C30H34ClF3N4O7S

【 分 子 量 】687.14028

【开发单位】AstraZeneca (Originator)

【药理作用】Chronic Obstructive Pulmonary Diseases (COPD), Treatment of, Pulmonary Emphysema, Agents for, Respiratory Distress Syndrome, Agents for, RESPIRATORY DRUGS, Elastase Inhibitors

合成路线1

The synthetic sequence used for the manufacture of ICI 200,880 is as follows: Carbodiimide-mediated coupling of acid (I) with amine (II) followed by ester hydrolysis with HCl affords acid (III). The other key intermediate, amino alcohol (VI), is prepared via alkylation of nitro-alkane (IV) with trifluoroacetaldehyde followed by reduction of the resulting nitro alcohol (V). Coupling of acid (III) with amino alcohol (VI) followed by oxidation with KMnO4 affords ICI 200,880. Since ICI 200,880 is an amorphous solid, it cannot be purified by crystallization. However, when acid (III) is purified by crystallization as its calcium salt and amino alcohol (VI) is purified by flash distillation, then the final coupling and oxidation proceed to yield ICI 200,880 of excellent purity.

1 Edwards, P.D.; ICI 200880. Drugs Fut 1995, 20, 7, 662.
2 Bergeson, S.H.; Schwartz, J.A.; Stein, M.M.; Wildonger, R.A.; Edwards, P.D.; Shaw, A.; Trainor, D.A.; Wolanin, D.J. (AstraZeneca LP); Peptide derivs. AU 8652623; EP 0189305; ES 8706169; ES 8707551; ES 8802526; JP 1986218518; JP 1993246984; US 4910190; US 5055450; US 5194588 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 11780 4-([[(4-Chlorophenyl)sulfonyl]amino]carbonyl)benzoic acid C14H10ClNO5S 详情 详情
(III) 11781 (2S)-1-((2S)-2-[[4-([[(4-Chlorophenyl)sulfonyl]amino]carbonyl)benzoyl]amino]-3-methylbutanoyl)-2-pyrrolidinecarboxylic acid C24H26ClN3O7S 详情 详情
(IV) 11782 2-Methyl-1-nitropropane C4H9NO2 详情 详情
(V) 11783 1,1,1-Trifluoro-4-methyl-3-nitro-2-pentanol C6H10F3NO3 详情 详情
(VI) 11784 3-Amino-1,1,1-trifluoro-4-methyl-2-pentanol C6H10F3NO3 详情 详情
(VII) 11785 (2S)-1-((2S)-2-[[4-([[(4-Chlorophenyl)sulfonyl]amino]carbonyl)benzoyl]amino]-3-methylbutanoyl)-N-(3,3,3-trifluoro-2-hydroxy-1-isopropylpropyl)-2-pyrrolidinecarboxamide C30H36ClF3N4O7S 详情 详情
Extended Information